Antibody to N-terminal region of hemoglobin β-chain
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 27, 2015
Grant Date -
Dec 22, 2011
app pub date -
Dec 10, 2009
filing date -
Dec 11, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Provided is a general-purpose technique capable of measuring the HbA1c content, which is comparable to the IFCC reference method. An antibody which reacts with a peptide or a protein having an amino acid sequence of VHLTPE (SEQ ID NO: 1) at the N-terminus in which the N-terminal valine is not modified, but does not react with a peptide or a protein in which the N-terminal valine of the relevant polypeptide or protein is modified.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully